Total Payments
$1,710
2024 Payments
$420.25
Companies
13
Transactions
60
Medicare Patients
3,589
Medicare Billing
$318,512
Payment Breakdown by Category
Food & Beverage$1,271 (74.3%)
Education$438.97 (25.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,271 | 54 | 74.3% |
| Education | $438.97 | 6 | 25.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $551.12 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $273.43 | 9 | $0 (2024) |
| ABBVIE INC. | $208.61 | 9 | $0 (2024) |
| Incyte Corporation | $204.66 | 4 | $0 (2024) |
| Galderma Laboratories, L.P. | $171.37 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $62.47 | 3 | $0 (2022) |
| Dermavant Sciences, Inc. | $54.92 | 3 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $53.11 | 3 | $0 (2024) |
| Journey Medical Corporation | $46.17 | 2 | $0 (2022) |
| GENZYME CORPORATION | $36.10 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $420.25 | 17 | Janssen Biotech, Inc. ($150.69) |
| 2023 | $225.62 | 7 | Janssen Biotech, Inc. ($124.80) |
| 2022 | $691.57 | 26 | Janssen Biotech, Inc. ($248.00) |
| 2021 | $84.88 | 4 | AbbVie Inc. ($41.38) |
| 2020 | $44.20 | 2 | Janssen Biotech, Inc. ($27.63) |
| 2019 | $99.52 | 1 | Galderma Laboratories, L.P. ($99.52) |
| 2017 | $144.40 | 3 | Novartis Pharmaceuticals Corporation ($110.36) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: ACNE | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Immunology | ||||||
| 07/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: DERMATOLOGY | ||||||
| 07/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Immunology | ||||||
| 06/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: DERMATOLOGY | ||||||
| 05/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Dermatology | ||||||
| 04/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Dermatology | ||||||
| 04/03/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $83.00 | General |
| 04/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: Immunology | ||||||
| 03/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Dermatology | ||||||
| 02/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Immunology | ||||||
| 02/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: Immunology | ||||||
| 02/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: Immunology | ||||||
| 12/28/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 12/20/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.91 | General |
| 12/12/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: Immunology | ||||||
| 11/01/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.17 | General |
| 05/16/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Dermatology | ||||||
| 03/21/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/27/2022 | Incyte Corporation | — | Education | Cash or cash equivalent | $84.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 960 | 1,864 | $321,260 | $90,619 |
| 2022 | 12 | 974 | 1,609 | $303,039 | $83,686 |
| 2021 | 12 | 846 | 1,584 | $277,293 | $80,280 |
| 2020 | 13 | 809 | 3,787 | $244,486 | $63,927 |
Total Patients
3,589
Total Services
8,844
Medicare Billing
$318,512
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 346 | $78,542 | $25,508 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 155 | $51,460 | $16,038 | 31.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 141 | 160 | $49,760 | $14,122 | 28.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 132 | 202 | $43,026 | $9,850 | 22.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 82 | 82 | $27,880 | $7,333 | 26.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 55 | 71 | $25,205 | $7,260 | 28.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 108 | 760 | $24,320 | $4,607 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $10,710 | $2,693 | 25.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 29 | 38 | $6,384 | $1,832 | 28.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 29 | $3,973 | $1,376 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 254 | 349 | $79,223 | $25,967 | 32.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 153 | 175 | $54,425 | $14,205 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 104 | $34,528 | $10,509 | 30.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 142 | 189 | $40,257 | $9,545 | 23.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 89 | 89 | $30,260 | $7,546 | 24.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 43 | 47 | $16,685 | $4,603 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $13,260 | $3,532 | 26.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 110 | 542 | $17,344 | $3,342 | 19.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 27 | 34 | $5,712 | $1,707 | 29.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 11 | 23 | $5,934 | $1,019 | 17.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 19 | $2,603 | $934.19 | 35.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 12 | 12 | $2,808 | $776.64 | 27.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 213 | 305 | $69,235 | $24,404 | 35.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 154 | 176 | $54,736 | $16,220 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 95 | $31,540 | $10,367 | 32.9% |
About Dr. Heather Schultz, MD
Dr. Heather Schultz, MD is a Dermatology healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1629262142.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heather Schultz, MD has received a total of $1,710 in payments from pharmaceutical and medical device companies, with $420.25 received in 2024. These payments were reported across 60 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,271).
As a Medicare-enrolled provider, Schultz has provided services to 3,589 Medicare beneficiaries, totaling 8,844 services with total Medicare billing of $318,512. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location White Plains, NY
- Active Since 08/28/2007
- Last Updated 10/21/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1629262142
Products in Payments
- TREMFYA (Drug) $551.12
- COSENTYX (Biological) $219.47
- RINVOQ (Biological) $165.32
- DUPIXENT (Biological) $98.57
- VTAMA (Drug) $54.92
- QBREXZA (Drug) $46.17
- SKYRIZI (Biological) $43.29
- Zoryve (Drug) $38.20
- AKLIEF (Drug) $37.81
- OPZELURA (Drug) $36.67
- ORACEA (Drug) $34.04
- COSENTYX (Drug) $32.79
- AMZEEQ (Drug) $19.88
- XIAFLEX (Biological) $15.71
- Absorica LD (Drug) $12.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in White Plains
Dr. Rhoda Narins, Md, MD
Dermatology — Payments: $71,781
Dermatology $71,781
Mr. Robert Berger, M.d, M.D
Dermatology — Payments: $12,738
Dermatology $12,738
Philip Fried, Md, MD
Dermatology — Payments: $5,202
Dermatology $5,202
Marc Grossman, M.d, M.D
Dermatology — Payments: $750.00
Dermatology $750.00
Dr. Adnan Mir, Md, MD
Dermatology — Payments: $336.71
Dermatology $336.71
Ms. Channa Ovits
Dermatology — Payments: $211.60
Dermatology $211.60